Atlas Trials

Chi-GVM Regimen for the Treatment of R/R PTCL

Clinical trial NCT06211881 · UNKNOWN

Trial details

NCT number
NCT06211881
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed/Refractory Peripheral T-cell Lymphoma
Start date
2023-10-25
Primary completion
2025-09-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.